Stockscreener 앱 받기
19.54
2.90%
0.55
시장 영업 전:
19.85
0.31
+1.59%
전일 마감가:
$18.99
열려 있는:
$19.39
하루 거래량:
54,974
Relative Volume:
0.75
시가총액:
$230.10M
수익:
$19.85M
순이익/손실:
$-12.75M
주가수익비율:
-14.16
EPS:
-1.38
순현금흐름:
$-21.94M
1주 성능:
-1.21%
1개월 성능:
-4.07%
6개월 성능:
+9.22%
1년 성능:
+34.57%
1일 변동 폭
$19.38
$19.87
1주일 범위
$18.50
$19.89
52주 변동 폭
$14.14
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
MDWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
19.54 | 230.10M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.27 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
522.27 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.00 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
568.06 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
266.80 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-02 | 개시 | Alliance Global Partners | Buy |
| 2025-02-28 | 개시 | Craig Hallum | Buy |
| 2024-07-16 | 재확인 | Maxim Group | Buy |
| 2022-12-22 | 개시 | Maxim Group | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-09-23 | 개시 | BTIG Research | Buy |
| 2016-11-28 | 개시 | Aegis Capital | Buy |
| 2016-08-17 | 개시 | Wells Fargo | Outperform |
| 2014-04-16 | 개시 | Oppenheimer | Outperform |
모두보기
Mediwound Ltd 주식(MDWD)의 최신 뉴스
Bank of America Corp DE Has $141,000 Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
(MDWD) On The My Stocks Page - news.stocktradersdaily.com
Analysts Set MediWound Ltd. (NASDAQ:MDWD) PT at $31.25 - Defense World
When (MDWD) Moves Investors should Listen - news.stocktradersdaily.com
MediWound (NASDAQ:MDWD) Now Covered by Oppenheimer - Defense World
Oppenheimer assumes MediWound stock at outperform, sets $34 PT By Investing.com - Investing.com India
Oppenheimer assumes MediWound stock at outperform, sets $34 PT - Investing.com
Oppenheimer Adjusts MediWound Price Target to $34 From $36, Maintains Outperform Rating - marketscreener.com
MediWound (MDWD) Garners Outperform Rating with Strategic Advanc - GuruFocus
Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth - Yahoo Finance
What is HC Wainwright’s Forecast for MediWound Q2 Earnings? - Defense World
Northern Trust Corp Has $2.58 Million Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound (NASDAQ:MDWD) PT Set at $31.00 by HC Wainwright - Defense World
Where are the Opportunities in (MDWD) - news.stocktradersdaily.com
H.C. Wainwright lifts MediWound stock target to $31, maintains buy By Investing.com - Investing.com South Africa
H.C. Wainwright lifts MediWound stock target to $31, maintains buy - Investing.com
MDWD: HC Wainwright & Co. Raises Price Target for MediWound | MD - GuruFocus
MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock News - GuruFocus
MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock New - GuruFocus
MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline - Yahoo Finance
MediWound’s Q1 2025: Strategic Progress Amid Financial Challenges - TipRanks
Mediwound earnings beat by $0.58, revenue fell short of estimates - Investing.com India
MediWound (MDWD) Q1 2025 Earnings Call Transcript - Mitrade
MediWound: Q1 Earnings Snapshot - MySA
MediWound Q1 2025 Earnings Call Transcript - MarketBeat
Transcript : MediWound Ltd., Q1 2025 Earnings Call, May 21, 2025 - marketscreener.com
MediWound Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MediWound Ltd. Reaffirms Revenue Guidance for the Year 2025 - marketscreener.com
MediWound (MDWD) Projects Revenue Growth for Fiscal Year 2025 | - GuruFocus
MediWound Announces Q1 2025 Results and Updates on Key Trials - TipRanks
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
MediWound (MDWD): Q1 Revenue Falls Short, Strategic Growth Plans Intact | MDWD Stock News - GuruFocus
MediWound Expands Global Reach: Major Wound Care Players Join Clinical Trials as Revenue Targets $24M - Stock Titan
Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result - GuruFocus
MediWound Stock: Undervalued High-Growth Potential (NASDAQ:MDWD) - Seeking Alpha
MediWound Announces Key Approvals at 2025 Shareholder Meeting - TipRanks
We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth - simplywall.st
MediWound (MDWD) to Release Earnings on Wednesday - Defense World
MediWound (MDWD) Showcases Phase II Trial Results in Wound Care - GuruFocus
EscharEx shows promise in venous ulcer treatment - Investing.com Australia
MediWound Announces Publication of Phase II EscharEx® Data Demon - GuruFocus
MediWound Announces Publication of Phase II EscharEx® Data - GlobeNewswire
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers - Stock Titan
Barclays PLC Raises Stock Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound Ltd. (NASDAQ:MDWD) Shares Sold by Renaissance Technologies LLC - Defense World
Mediwound Ltd (MDWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.29%
자본화:
|
볼륨(24시간):